Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations Terminated Phase 1 Trials for TAS-117 (DB15054)

IndicationStatusPhase
DBCOND0137462 (Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04770246TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN MutationsTreatment